Fort Worth, Texas — According to state and local development sources, Kedplasma plans to invest $4,200,000.00 to build out 11,097 square feet of new space in Fort Worth. The company plans to occupy the new space at SEC N Riverside & Grapewood in Fort Worth, on or about 9/1/2024. According to the company website KEDPLASMA specializes in the collection of high-quality plasma that is processed into plasma-based therapies to respond to patients needs the world over. KEDPLASMA is a subsidiary of Kedrion Biopharma, an international company that produces and distributes plasma-derived medicinal products for use in treating serious disorders such as hemophilia and immune system deficiencies. KEDPLASMA owns collection centers in the US.Plasma cannot be produced artificially. It is obtained only through the generosity of donors volunteers who contribute a precious donation to others. KEDPLASMA seeks to increase donor participation by making donation easy, comfortable and safe and by educating donors about how their donations help Keep Life Flowing.

To learn more about Kedplasma, visit http://kedplasma.us/

Company Contact:
Bob Rossilli, Chief Commercial Officer
https://www.linkedin.com/in/bobrossilli/
201-242-8900

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.